Focus Taiwan App
Download

Taiwan's Adimmune Corp. signs benefit-sharing agreement with WHO

05/14/2024 08:49 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan-based vaccine maker Adimmune Corp. on Tuesday said it has signed an agreement with the World Health Organization (WHO) to receive early biological samples of emerging influenza variants.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.62